IQQA-BodyImaging Surgical Planning Platform

IQQA-BodyImaging serves as the treatment planning and assessment component of EDDA Technology’s IQQA platform, providing precision 3D imaging analytics for cancer management. The software has been FDA cleared and deployed in clinical settings with documented applications exceeding 100,000 cases, primarily supporting treatment of liver, kidney, and lung cancers.

Product Overview

IQQA-BodyImaging transforms standard medical imaging data into fully quantified, patient-specific 3D anatomic models that support clinical decision-making across the treatment cycle. The platform addresses key challenges in cancer treatment planning by providing accurate tumor volumetry, vascular anatomy visualization, and surgical margin assessment.

The software integrates with the broader IQQA ecosystem, enabling direct workflow from pre-operative planning through intra-operative navigation (via IQQA-Guide) to post-operative assessment and follow-up evaluation.

Key Features

IQQA-BodyImaging is an FDA-cleared 3D imaging analytics platform by EDDA Technology, applied across 100,000+ cancer cases for tumor volumetry, vascular mapping, and treatment simulation in liver, kidney, and lung oncology.

• Multimodality Image Processing: Converts CT, MRI, and other imaging data into detailed 3D anatomic reconstructions
• Quantitative Analysis: Provides precise measurements of tumor volume, anatomic distances, and surgical margins
• Treatment Planning: Supports surgical approach planning, ablation zone estimation, and treatment simulation
• Follow-up Assessment: Enables comparison of pre- and post-treatment imaging for outcome evaluation
• Cloud-Based Access: Available through IQQA OnDemand cloud services for remote accessibility

Technical Specifications

IQQA-BodyImaging processes CT, MRI, and PET-CT inputs to produce 3D anatomic models and quantitative measurements, available on-premises or through IQQA OnDemand cloud services.

Clinical Applications

Pre-operative Planning

• Tumor localization and volumetric analysis
• Vascular anatomy mapping for surgical approach optimization
• Surgical margin estimation and resection planning
• Treatment simulation for complex cases

Oncology Support

• Liver tumor treatment planning including hepatectomy and ablation
• Kidney cancer surgical planning
• Lung nodule characterization and treatment planning
• Multi-disciplinary team (MDT) case presentation support

Post-operative Assessment

• Treatment response evaluation
• Recurrence monitoring
• Long-term follow-up comparison

Clinical data indicates that IQQA-BodyImaging has provided significant time savings and improved patient care in cancer treatment settings.

Regulatory Status

Frequently Asked Questions

What types of cancer does IQQA-BodyImaging support?

IQQA-BodyImaging has been primarily deployed for liver, kidney, and lung cancer management, supporting treatment planning, surgical guidance, and post-operative assessment. The platform’s capabilities extend to other solid organ tumors where 3D anatomic visualization and quantitative analysis provide clinical value.

Can IQQA-BodyImaging be accessed remotely?

Yes, EDDA Technology offers IQQA OnDemand cloud-based services that provide access to IQQA-BodyImaging applications through a web-enabled platform. This enables treatment planning and assessment capabilities without requiring on-premises installation.

How does IQQA-BodyImaging integrate with surgical navigation?

IQQA-BodyImaging works as part of the integrated IQQA platform. Treatment plans and 3D anatomic models created in IQQA-BodyImaging can be transferred to IQQA-Guide for intra-operative navigation, enabling continuity from planning through execution of surgical procedures.